More than 3,500 COVID-19 related deaths have now been reported in the United States. That number tops those reported in all of China, but there is a hopeful sign right here in Chicago. COVID-19 patients are undergoing an experimental treatment at Northwestern with a drug that was used to treat Ebola patients.
Now two hospitals, Northwestern Memorial Hospital and University of Illinois at Chicago Medical Center, are part of an international trial to see if it could help treat COVID-19 as well. It is a double-blind trial, meaning that neither the doctor nor the patients knows if they’re on the drug, but they are hopeful they could see some results soon.
“This is one looking at an agent specifically targeting the virus,” said Dr. Michael Angarone, a Northwestern Medicine infectious disease physician. “And so we’re all really hopeful that this is going to show some benefit. Obviously ideal would be this shows benefit to everyone no matter what stage of disease you have.”